Alkermes reports positive top-line Phase Ib trial data for ALKS 7290 Clinical Trials Arena 10:42 Tue, 22 Sep
STAT Plus: Pharmalittle: We’re reading about Novo plans to expand its pipeline, early Alkermes ADHD data, and more STAT 14:35 Mon, 21 Sep
Alkermes Announces Positive Phase 1b Results Demonstrating Clinical Proof-of-Concept for Alks 7290 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD) Business Wire (Press Release) 12:06 Mon, 21 Sep
STAT Plus: Alkermes’ orexin agonist shows potential to treat ADHD in early-stage trial STAT 12:03 Mon, 21 Sep
Alkermes Announces Appointment of Anne C. Whitaker to Board of Directors Business Wire (Press Release) 12:05 Wed, 16 Sep
Alkermes Announces Launch of 9th Annual Alkermes Pathways Research Awards® Program Business Wire (Press Release) 12:07 Thu, 10 Sep
The Lancet Neurology Publishes Data From Alkermes’ Positive Vibrance-1 Phase 2 Study of Alixorexton in Adults With Narcolepsy Type 1 Business Wire (Press Release) 23:33 Mon, 24 Aug
